Thymalin: research, legal status and who sells it
This page is information, not medical advice. Thymalin is not approved as a medicine in the markets below unless stated. We don't publish dosing or usage instructions.
- Category
- Thymus-derived peptide preparation
- Price range
- $1.00/mg to $6.32/mg, median $3.50/mg across 22 vendors (compare)
- Our lab tests
- None yet (how testing will work)
Legal and regulatory status
| Where | Status |
|---|---|
| United States | No FDA-approved drug contains thymalin [1]. |
| United Kingdom | No UK-licensed medicine containing thymalin appears in the MHRA products database [2]. |
| European Union | No medicine containing thymalin is authorized in the EU, according to EMA's central and Article 57 product data [3][4]. |
| Canada | No product containing thymalin appears in Health Canada's Drug Product Database [5]. |
| Australia | Thymalin is not named in Australia's Poisons Standard (October 2026) [6]. |
| Sport (WADA) | Not named on the 2026 Prohibited List [7]. |
We haven't published a full overview of Thymalin yet. The legal status table and live prices on this page are current.
Thymalin prices: cheapest listings
The five lowest $/mg listings out of 24. See all Thymalin prices
| Vendor | Transparency | Product | Size | Price | $/mg | Stock | Vendor's page |
|---|---|---|---|---|---|---|---|
| Chimera Peptides | 27 | 10 mg × 20 | $200 | $1.00/mg | View | ||
| Chimera Peptides | 27 | 10 mg × 10 | $116 | $1.16/mg | View | ||
| Peptides World | 80 | 50 mg | $85 | $1.70/mg | View | ||
| Polaris Peptides | 45 | Thymulin 100mg (Thymalin) | 100 mg | $185 | $1.85/mg | View | |
| Bulk Peptide Wholesale | 45 | 10 mg × 10 | $200 | $2.00/mg | View |
Sources
- Drugs@FDA: FDA-Approved Drugs (database searched by active ingredient). U.S. Food and Drug Administration. Accessed Oct 14, 2026
- MHRA Products: licensed-medicine search for "thymalin". Medicines and Healthcare products Regulatory Agency (UK). Accessed Oct 14, 2026
- EMA medicines data: centrally authorised human medicines (export of 14 October 2026). European Medicines Agency. Accessed Oct 14, 2026
- EMA Article 57 product data: medicines authorised in the EU/EEA (data as of 9 October 2026). European Medicines Agency. Accessed Oct 14, 2026
- Drug Product Database online query (searched by active ingredient). Health Canada. Accessed Oct 14, 2026
- Therapeutic Goods (Poisons Standard—October 2026) Instrument 2026 (F2026L01327, registered 30 September 2026). Federal Register of Legislation, Australian Government. Accessed Oct 14, 2026
- World Anti-Doping Code International Standard: Prohibited List 2026 (in force 1 January 2026). World Anti-Doping Agency. Accessed Oct 14, 2026